📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
33%
📉 Score Deterioration
40%
• Score rose 29 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
🔄 Reverse Split
15%
• Only 4 months cash — financial pressure
💹 Market Data
Market Cap$101.60M
Shares Outstanding35.65M
Float24.92M
Cash$19.01M
Debt$1.06M
Short InterestN/A
🏛 Institutional Holdings
36.6% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest153.7K
Days to Cover3.5
% of Float0.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Nov 17, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NEXM
📊 NEXM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NEXM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.